Vietnam: 4,110 Cervical Cancer Deaths in 2024 Despite Available Vaccines, Low Screening

Cervical cancer killed an estimated 4,110 women in Vietnam in 2024, out of roughly 8,274 new cases recorded that year, according to GLOBOCAN data cited in the report.

The disease remains the second-leading cause of cancer-related deaths among women after breast cancer — despite preventive measures including human papillomavirus (HPV) vaccination and regular screening.

The figures matter because both prevention tools exist in the country today. HPV vaccination has been incorporated into Vietnam’s Expanded Programme on Immunisation, yet only 28.2% of women have undergone screening, according to national action plan implementation documents cited in the report.

The average age of women diagnosed with cervical cancer ranges from 48 to 52 — decades after the window in which vaccination and early detection do the most good. That gap between available prevention and actual uptake is the story behind the death toll.

Dr. Le Thi Kim Dung, former Deputy Director of the Institute for Reproductive and Family Health (RAFH), said vaccination is one of the most effective ways to prevent HPV-related diseases. Her point underlines the core public health argument: the virus is common, usually silent, and preventable.

HPV often causes no noticeable symptoms

  • HPV is a common virus that often causes no noticeable symptoms, allowing infections to go undetected.
  • Vaccination delivers its greatest benefit when given ahead of any contact with the virus — the World Health Organization (WHO) prioritises HPV vaccination for girls aged 9-14, ideally before exposure to the virus.
  • The vaccine does not protect against every cancer-causing HPV type, so vaccination does not replace cervical cancer screening.

An invisible virus, a delayed diagnosis

Human papillomavirus is a common virus that often causes no noticeable symptoms, allowing infections to go undetected. Cervical cancer accounts for a particularly large share of the disease burden linked to HPV. Among the biggest obstacles is the fact that cervical cancer may progress without clear warning signs, which makes catching it early nearly impossible unless routine screening is carried out.

The report describes the threat as largely invisible. Possible indications include vaginal bleeding that occurs outside of menstrual periods, bleeding following sexual activity, discharge from the vagina that is abnormal or has an unpleasant odour, pain in the pelvic region and discomfort or pain when urinating. When these signs eventually prompt patients to visit a doctor, the illness may by then have progressed to a late stage.

That asymmetry — a symptomless infection against a late-presenting cancer — is what makes the screening gap so consequential. According to health specialists, when screening uptake is low and HPV infection so often produces no symptoms, diagnoses can be postponed and chances for prompt treatment diminished.

Vietnam’s vaccination rollout begins in four provinces

Within Vietnam, HPV vaccines currently hold approval with a two-dose regimen for those aged 9-14 and a three-dose regimen for individuals aged 15 and above, based on the vaccination guidance referenced in the report. The WHO prioritises HPV vaccination for girls aged 9-14, ideally before exposure to the virus. Vaccination may also benefit boys and men, depending on national immunisation policies.

HPV vaccination has also been incorporated into Vietnam’s Expanded Programme on Immunisation. The first phase of the rollout is set to focus on girls aged 11 living in chosen underprivileged districts across four provinces: Tuyen Quang, Quang Ngai, Dak Lak and Vinh Long. The initiative aims to widen access to preventive healthcare for communities that may encounter obstacles in getting vaccinated.

Specialists in medicine stress that extending vaccination to more of the population can bolster protection across communities, curb the spread of the HPV types the vaccine targets and avert cancers linked to HPV down the line. Still, getting vaccinated is no substitute for cervical cancer screening, because the current vaccines do not cover all HPV types capable of causing cancer.

Vietnam’s cervical cancer burden at a glance

Measure Figure Source basis
New cases, 2024 8,274 GLOBOCAN data, cited in the report
Deaths, 2024 4,110 GLOBOCAN data, cited in the report
Women screened 28.2% National action plan implementation documents
Average age at diagnosis 48 to 52 The report
WHO vaccination priority Girls aged 9-14 WHO guidance cited in the report

What the numbers do not yet say

The report leaves several questions open. It does not say when the four-province rollout will widen nationally, nor does it give a target coverage rate for the immunisation programme. It also does not quantify how many of the 2024 deaths involved women who had never been screened.

What the sources do establish is the scale of the gap: national action plan implementation documents indicate that just 28.2% of women have been screened, which represents a considerable shortfall in preventive healthcare, together with recorded estimates of 8,274 new cases and 4,110 deaths in 2024. Closing that distance — through the childhood vaccination programme and expanded screening — is the stated intent of the national plan documents the report cites.

Dosing schedules differ by age group

The number of doses varies according to age: two doses are given to those aged 9-14, while individuals aged 15 and above receive three doses, based on the vaccination guidance referenced in the report.

Vietnam targets 11-year-old girls in four provinces

Vietnam’s inclusion of HPV vaccination in its Expanded Programme on Immunisation marks the practical turning point in this story. The first phase of the rollout is set to focus on girls aged 11 living in chosen underprivileged districts across four provinces: Tuyen Quang, Quang Ngai, Dak Lak and Vinh Long.

The combined strategy the report describes is unambiguous: pairing vaccination with consistent screening and prompt medical attention continues to be vital for lowering how often cervical cancer occurs and how many die from it. That combination, experts say, is what stands between Vietnam’s current toll and the preventable fraction of it.

Dr. Le Thi Kim Dung emphasised the importance of vaccination in preventing HPV-related diseases, stating that proactive vaccination is one of the most effective ways to protect against infections caused by the virus — delivered as HPV vaccination was incorporated into Vietnam’s Expanded Programme on Immunisation, with an initial rollout targeting 11-year-old girls in four provinces.

References

  • GLOBOCAN cancer incidence and mortality estimates for Vietnam, 2024, as cited in the report
  • National action plan implementation documents on cervical cancer screening coverage, cited in the report
  • World Health Organization guidance on HPV vaccination priority groups (girls aged 9-14), cited in the report
  • Vietnam’s Expanded Programme on Immunisation HPV vaccine rollout documentation, cited in the report
  • Interview with Dr. Le Thi Kim Dung, former Deputy Director of the Institute for Reproductive and Family Health (RAFH), cited in the report

Readers should consult a qualified healthcare professional about vaccination, screening or any symptoms described above.

Photo of author

Health Desk

Health Desk at Archyde.

Buurman’s 87th-Minute Winner Moves Chelsea Top of WCL League Phase